Up to the test? Routine HIV testing in everyday clinical practice

International Journal of Clinical Practice

Volumn 66, Issue 5, 2012, Pages 425-430

  Duncan, S ^a   Sathia, L ^b  

^a BERKSHIRE HEALTHCARE NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL THERAPY; ATTITUDE TO HEALTH; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DELAYED DIAGNOSIS; DRUG EFFICACY; HEALTH CARE QUALITY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; LIFE EXPECTANCY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCREENING TEST; UNITED KINGDOM; VIRUS DIAGNOSIS; VIRUS LOAD;

EARLY DIAGNOSIS; GREAT BRITAIN; HIV INFECTIONS; HUMANS; INFORMED CONSENT; MASS SCREENING; PRACTICE GUIDELINES AS TOPIC; PROFESSIONAL PRACTICE; RISK FACTORS; UNITED STATES;

EID: 84860112635     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2012.02901.x     Document Type: Review

References (63)

1. Mocroft A, Ledergerber B, Katlama C, et al., "Decline in the AIDS and death rates in the EuroSIDA study: an observational study". Lancet 2003; 362: 22-9. (Pubitemid 36835816)
2. British Co-operative Clinical Group. Screening for HIV infection in genitourinary medicine clinics: a lost opportunity? Sex Transm Infect 2000; 76: 307-10.
3. Paxton S,. Public disclosure of serostatus-the impact on HIV-positive people. Sex Health Exch 2000; 1: 13-4.
4. Oxenius A, Price DA, Easterbrook PJ, et al., Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes. Proc Natl Acad Sci USA 2000; 97: 3382-7. (Pubitemid 30183311)
5. Palella FJ Jr, Delaney KM, Moorman AC, et al., Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338: 853-60. (Pubitemid 28135961)
6. Bower M, Palmieri C, Dhillon T,. AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy. Curr Opin Infect Dis 2006; 19: 14-9. (Pubitemid 43032434)
7. van Sighem AI, G L, Reiss P, Brinkman K, de Wolf F,; ATHENA national observational cohort study. "Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals". AIDS 2010; 24: 1527-35.
8. Vernazza P, Hirschel B, Bernasconi E, et al., Les personnes séropositives ne souffrant d'aucune autre MST et suivant un traitment antirétroviral efficace ne transmettent pas le VIH par voie sexuelle (An HIV-infected person on antiretroviral therapy with completely suppressed viraemia ("effective ART") is not sexually infectious). Bulletin des Médecins Suisses, 2008, 89, 165-9. (accessed December 2011).
9. Marks G, Crepaz N, Senterfitt JW, Janssen RS,. Meta-analysis of high-risk sexual behaviour in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr 2005; 39: 446-53. (Pubitemid 41003791)
10. Colucci A, Balzano R, Camoni L, et al., "Characteristics and behaviors in a sample of patients unaware of their infection until AIDS diagnosis in Italy: a cross-sectional study". AIDS Care 2011; 23: 1067-75.
11. Duffus WA, Davis HT, Byrd MD, Heidari K, Stephens TG, Gibson JJ,. "HIV Testing in Women: Missed Opportunities". J Womens Health (Larchmt) 2012; 21: 170-8.
12. Health Protection Agency (HPA), Centre for Infections, the UK Collaborative Group for HIV and STI Surveillance. Testing Times. HIV and Other Sexually Transmitted Infections in the United Kingdom. 2007. (accessed December 2011).
13. Marks G, Crepaz N, Janssen RS,. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS, 2006; 20: 1447-50. (Pubitemid 43948252)
14. Margolis AD, Joseph H, Belcher L, et al., "'Never Testing for HIV' Among Men Who Have Sex with Men Recruited from a Sexual Networking Website, United States". AIDS Behav 2012; 16: 23-9.
15. Massari V, Lapostolle A, Cadot E, et al., "Gender, socio-economic status, migration origin and neighbourhood of residence are barriers to HIV testing in the Paris metropolitan area". AIDS Care 2011; 23: 1609-18.
16. Schwarcz S, Richards TA, Frank H, et al., "Identifying barriers to HIV testing: personal and contextual factors associated with late HIV testing". AIDS Care 2011; 23: 892-900.
17. Stöhr W, Dunn DT, Porter K, et al.,; on behalf of the UK CHIC Study. CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997-2003. HIV Med, 2007; 8: 135-41. (Pubitemid 46915683)
18. Krentz HB, Auld MC, Gill MJ,. The high cost of medical care for patients who present late (CD4 < 200 cells/μl) with HIV infection. HIV Medicine, 2004; 5: 93-8. (Pubitemid 38404662)
19. Griffith R, Mandalia S, Beck EJ, et al., HIV media campaigns and HIV-1 testing trends at London genitourinary medicine clinic, 1985-1993. AIDS 1995; 9: 1367-72.
20. The Health Protection Agency. HIV in the United Kingdom: 2010 Report. (accessed August 2011).
21. British HIV Association (BHIVA). 2005-6 mortality audit. (accessed December 2011).
22. Briggs A, Partridge DG, Bates S,. "HIV testing in colposcopy and termination of pregnancy services: a missed opportunity?" J Fam Plann Reprod Health Care 2011; 37: 201-3.
23. Goodall L, Leen C,. Late diagnosis of HIV: could this be avoided? Scott Med J 2011; 56: 84-6.
24. Rodger AJ, Curtis H, Sabin C, Johnson M,; British HIV Association (BHIVA) and BHIVA Clinical Audit and Standards Sub-Committee. Assessment of hospitalizations among HIV patients in the UK: a national cross-sectional survey. Int J STD AIDS 2010; 21: 752-4.
25. Read P, Armstrong-James D, Tong CY, Fox J,. Missed opportunities for HIV testing-a costly oversight. QJM. 2011; 104: 421-4 Epub 2010 Dec 5.
26. UK national Screening Committee. Programme appraisal criteria. Criteria for appraising the viability, effectiveness and appropriateness of a screening programme. (accessed October 2011).
27. Sanders GD, Bayoumi AM, Sundaram V, et al., Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. New Engl J Med, 2005; 352: 570-85. (Pubitemid 40204670)
28. British HIV Association, British Association for Sexual Health and HIV and the British Infection Society. UK National HIV Testing Guidelines. September 2008. (accessed August 2011).
29. NICE public health guidance 34: Increasing the uptake of HIV testing among men who have sex with men. March 2011. (accessed October 2011).
30. NICE public health guidance 33: Increasing the uptake of HIV testing to reduce undiagnosed infection and prevent transmission among black African communities living in England. March 2011. (accessed October 2011).
31. The National Institute for Health and Clinical Excellence. "NICE calls for routine offer of HIV tests in high prevalence areas". March 2011. (accessed October 2011).
32. The Health Protection Agency (HPA). Time to test for HIV: expanded healthcare and community HIV testing in England. 2011. (accessed October 2011).
33. Cohan D, Gomez E, Charlebois E,. Patient perspectives and testing uptake with abbreviated versus standard pretest HIV Counseling in the prenatal setting: a randomized-controlled, non-inferiority trial. CROI 2008. Abstract 535a.
34. Department of Health (2003). Screening for Infectious Diseases in Pregnancy. (accessed December 2011).
35. Department of Health (DH) (2001). Better Prevention, Better Services, Better Sexual Health-The National Strategy for Sexual Health and HIV. (accessed December 2011).
36. MacPherson P, Chawla A, Jones K, et al., Feasibility and acceptability of point of care HIV testing in community outreach and GUM drop-in services in the North West of England: a programmatic evaluation. BMC Public Health 2011; 11: 419.
37. Simpson WM, Johnstone FD, Boyd FM, Goldberg DJ, Hart GJ, Prescott RJ,. Uptake and acceptability of antenatal HIV testing: randomised controlled trial of different methods of offering the test. BMJ 1998; 316: 262-7. (Pubitemid 28121217)
38. Centers for Disease Control and Prevention (CDC). Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR, 2006; 55: 1-17. (accessed December 2011)
39. Centers for Disease Control and Prevention (CDC). "Results of the expanded HIV testing initiative-25 jurisdictions, United States, 2007-2010". MMWR Morb Mortal Wkly Rep 2011; 60: 805-10.
40. Haukoos JS, Hopkins E, Hull A, et al., "HIV testing in emergency departments in the United States: a national survey". Ann Emerg Med 2011; 58 (1 Suppl. 1): S10-6. e11-8
41. Rothman RE, Hsieh YH, Harvey L, et al., "2009 US emergency department HIV testing practices". Ann Emerg Med 2011; 58 (1 Suppl. 1): S3-9. e1-4.
42. Sattin RW, Wilde JA, Sattin RW, et al., "Rapid HIV testing in a southeastern emergency department serving a semiurban-semirural adolescent and adult population". Ann Emerg Med 2011; 58 (1 Suppl. 1): S60-4.
43. Batey DS, Hogan VL, Cantor R, et al., "Routine HIV testing in the emergency department: assessment of patient perceptions". AIDS Res Hum Retroviruses 2011. [epub ahead of print].
44. April MD, Chiosi JJ, Paltiel AD, Sax PE, Walensky RP,. "Projected survival gains from revising state laws requiring written opt-in consent for HIV testing". J Gen Intern Med 2011; 26: 661-7.
45. Christopoulos KA, Koester K, Weiser S, Lane T, Myers JJ, Morin SF,. "A comparative evaluation of the process of developing and implementing an emergency department HIV testing program". Implement Sci 2011; 6: 30.
46. Hecht CR, Smith MD, Radonich K, Kozlovskaya O, Totten VY,. "A comparison of patient and staff attitudes about emergency department-based HIV testing in 2 urban hospitals". Ann Emerg Med 2011; 58 (1 Suppl. 1): S28-32. e21-4.
47. Johnson CV, Mimiaga MJ, Reisner SL, Vanderwarker R, Mayer KH,. "Barriers and facilitators to routine HIV testing: perceptions from Massachusetts Community Health Center Personnel". AIDS Patient Care STDS 2011; 25: 647-55.
48. Kecojevic A, Lindsell CJ, Lyons MS, et al., "Public health and clinical impact of increasing emergency department-based HIV testing: perspectives from the 2007 conference of the National Emergency Department HIV Testing Consortium". Ann Emerg Med 2011; 58 (1 Suppl. 1): S151-9. e151
49. Walensky RP, Reichmann WM, Arbelaez C, et al., "Counselor- versus provider-based HIV screening in the emergency department: results from the universal screening for HIV infection in the emergency room (USHER) randomized controlled trial". Ann Emerg Med 2011; 58 (1 Suppl. 1): S126-32. e121-4
50. d'Almeida KW, Kierzek G, de Truchis P, et al., "Modest public health impact of nontargeted human immunodeficiency virus screening in 29 emergency departments". Arch Intern Med 2012; 172: 12-20.
51. Tripathi A, Gardner LI, Ogbuanu I, et al., "Predictors of time to enter medical care after a new HIV diagnosis: a statewide population-based study". AIDS Care 2011; 23: 1366-73.
52. Peck L, Ferenczi E, Burns F, Cosgrove C, Brown M,. Barriers to targeted HIV testing on an acute admissions unit: evaluation of the UK guideline. QJM. 2010; 103: 147-51 Epub 2009 Dec 29.
53. Gupta ND, Lechelt M,. "Assessment of the implementation and knowledge of the UK National Guidelines for HIV Testing (2008) in key conditions at a UK district general hospital". Int J STD AIDS 2011; 22: 102-4.
54. The Health Protection Agency (HPA). HIV in the United Kingdom: 2010 Report. (accessed October 2011).
55. Rodger AJ, Story A, Fox Z, Hayward A,; London Tuberculosis Nurses Network. HIV prevalence and testing practices among tuberculosis cases in London: a missed opportunity for HIV diagnosis? Thorax 2010; 65: 63-9.
56. Page I, Phillips M, Flegg P, Palmer R,. The impact of new national HIV testing guidelines at a district general hospital in an area of high HIV seroprevalence. J R Coll Physicians Edinb 2011; 41: 9-12.
57. Sathia L, Duncan S,; on behalf of the SHARP Project Team. SHARP Project has detected new HIV diagnoses. BMJ 2011; 343: d4358.
58. Bokhour BG, Solomon JL, Knapp H, Asch SM, Gifford AL,. Barriers and facilitators to routine HIV testing in VA primary care. J Gen Intern Med 2009; 24: 1109-14.
59. Dowson L, Kober C, Perry N, Fisher M, Richardson D,. "Why some MSM present late for HIV testing: a qualitative analysis". AIDS Care 2012; 24: 204-9.
60. Chan SY, Hill-Tout R, Rodgers M, Cormack I,. "Acceptance of HIV testing in medical inpatients: a local acceptability study". Int J STD AIDS 2011; 22: 187-9.
61. Kucirka LM, Sarathy H, Govindan P, et al., Risk of window period HIV infection in high infectious risk donors: systematic review and meta-analysis. Am J Transplant. 2011; 11: 1176-87. doi: Epub 2011 Mar 2.
62. Murphy G, Aitken C,. "HIV testing-the perspective from across the pond". J Clin Virol 2011; 52 (Suppl 1): S71-6.
63. Munro HL, Lowndes CM, Daniels DG, Sullivan AK, Robinson AJ,. National study of HIV testing in men who have sex with men attending genitourinary clinics in the United Kingdom. Sex Transm Infect 2008; 84: 265-70 Epub 2007 Dec 20.